HilleVax, Inc. logo

HilleVax, Inc.

NASDAQ:HLVX

Overview | Financials
Company Name HilleVax, Inc.
Symbol HLVX
Currency USD
Price 1.86
Market Cap 93,262,379
Dividend Yield 0%
52-week-range 1.34 - 15.25
Industry Biotechnology
Sector Healthcare
CEO Dr. Robert M. Hershberg M.D., Ph.D.
Website https://www.hillevax.com

An error occurred while fetching data.

About HilleVax, Inc.

HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines. It is developing HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. The company is headquartered in Boston, Massachusetts.

Related Stocks

Rigel Pharmaceuticals, Inc. logo

Rigel Pharmaceuticals, Inc.

RIGL

18.93 USD

C4 Therapeutics, Inc. logo

C4 Therapeutics, Inc.

CCCC

1.42 USD

EyePoint Pharmaceuticals, Inc. logo

EyePoint Pharmaceuticals, Inc.

EYPT

8.42 USD

Heron Therapeutics, Inc. logo

Heron Therapeutics, Inc.

HRTX

2 USD

Absci Corporation logo

Absci Corporation

ABSI

2.79 USD

OraSure Technologies, Inc. logo

OraSure Technologies, Inc.

OSUR

3 USD

Fulcrum Therapeutics, Inc. logo

Fulcrum Therapeutics, Inc.

FULC

6.995 USD

Athira Pharma, Inc. logo

Athira Pharma, Inc.

ATHA

0.303 USD

ALX Oncology Holdings Inc. logo

ALX Oncology Holdings Inc.

ALXO

0.484 USD

BioXcel Therapeutics, Inc. logo

BioXcel Therapeutics, Inc.

BTAI

1.6 USD

Financials

Numbers are in millions USD

Numbers are in millions USD